3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
26
Gastrointestinal
5
Genitourinary
4
Breast
4
Head & Neck
3
Gynecologic
2
Dermatologic
2
CNS
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sarcoma
12
Osteosarcoma
9
Rhabdomyosarcoma
7
Neuroblastoma
7
Wilms Tumor
6
Rhabdoid Tumor
6
Lymphoma, Non-Hodgkin
6
Hepatoblastoma
6
Sarcoma, Ewing
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Glioma
5
Ependymoma
5
Central Nervous System Neoplasms
4
Liposarcoma
3
Carcinosarcoma
3
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Melanoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Cervical Neoplasms
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Cyclophosphamide
5
Radiosurgery
3
Oncolytic Virotherapy
3
Nivolumab
3
Injections
3
Gemcitabine
3
Drug Therapy
3
Biopsy
3
fludarabine
2
belinostat
2
Riluzole
2
Paclitaxel
2
Ipilimumab
2
Filgrastim
2
Docetaxel
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
Bortezomib
2
Blood Specimen Collection
2
Amifostine
2
AH 111585
2
tislelizumab
1
spartalizumab
1
seribantumab
1
selpercatinib
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
X-Rays
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled